Cost- Effectiveness and Quality of Life Assessment in Mood Disorder
NCT02870283 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 107
Last updated 2020-11-20
Summary
To evaluate the effectiveness of three systematic interventions for Bipolar Disorder (BD) mixed episodes using medications available in the Brazilian Public Healthcare System (SUS), and assessment of the quality of life of these patients.
A randomized pragmatic trial was conducted. An algorithm was developed for the treatment of episodes of bipolar mixed episodes.
Conditions
Interventions
- DRUG
- DRUG
-
Valproic Acid
- DRUG
-
Carbamazepine
Sponsors & Collaborators
-
Federal University of Rio Grande do Sul
lead OTHER
Principal Investigators
-
Marcelo Fleck, PhD · Federal University of Rio Grande do Sul
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2014-11-30
- Completion
- 2015-09-30
More Related Trials
-
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
NCT02893371 ·Status: TERMINATED
-
Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR
NCT00879307 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparative Effectiveness Study for Bipolar Disorder
NCT01331304 ·Status: COMPLETED ·Phase: PHASE4
-
Neuropsychological Characterization of Patients With Bipolar Disorder and a History of Suicide Attempt
NCT02116400 ·Status: WITHDRAWN
-
Cannabidiol as an Adjunctive Treatment for Bipolar Depression
NCT03310593 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
NCT01824602 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Evaluation of the Antidepressant Effect of the Use of Probiotics in Bipolar Disorder
NCT05762887 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
NCT01822678 ·Status: COMPLETED ·Phase: PHASE2
-
Anticipating Depressive and Manic Episodes in Bipolar Disorders Using Vocal Biomarkers
NCT07298278 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
NCT01272531 ·Status: COMPLETED
-
Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients
NCT02630888 ·Status: UNKNOWN ·Phase: PHASE2
-
A Psychoeducational Program "BalancingMySwing" for Patients With Bipolar Disorder
NCT04020289 ·Status: COMPLETED ·Phase: NA
-
Neurophysiologic Changes in Patients With Bipolar Depression
NCT01213121 ·Status: UNKNOWN ·Phase: PHASE4
-
Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder
NCT01126827 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
NCT00563992 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
NCT01396447 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
NCT06929273 ·Status: RECRUITING ·Phase: PHASE3
-
"Mindfulness vs Psychoeducation in Bipolar Disorder"
NCT02133170 ·Status: UNKNOWN ·Phase: NA
-
Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania
NCT00879632 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
NCT07140913 ·Status: RECRUITING ·Phase: PHASE3
-
Mood Stabilizer-induced Metabolic Abnormalities in Bipolar Disorder
NCT04486092 ·Status: UNKNOWN ·Phase: NA
-
Algorithm Guided Treatment Strategies for Bipolar Depression
NCT01938859 ·Status: UNKNOWN ·Phase: PHASE4
-
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
NCT06429722 ·Status: COMPLETED ·Phase: PHASE2
-
VALID : VAlproate Versus LIthium in Bipolar Disorders
NCT00264173 ·Status: COMPLETED ·Phase: PHASE4
-
Risk Factors for Development of Rapid Cycling in Bipolar Disorder Patients
NCT01992302 ·Status: COMPLETED